Clinical trials: GI Protozoa

Amoebic Dysentery, Giardiasis

Auranofin for Giardia Protozoa

• Completed
• Age: 18 to 65 years
• Phase 2
• Results posted

This is a phase IIa, randomized, placebo-controlled, single-blinded superiority treatment study in males and non-pregnant females, 18 to 65 years of age who are in good health.

Trial name

NCT02736968

Testing

Auranofin

Where

2 sites in Bangladesh

Volunteers

93 people

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)